HYDERABAD: IT and Industries Minister D Sridhar Babu on Thursday announced that the Congress government has secured ...

Climate change and mosquitos are creating an epidemic of dengue in Oaxaca, as researchers work to counteract the disease.

The likelihood for severe disease increases with repeated dengue infection. There already exists an approved vaccine (Sanofi’s Dengvaxia), but TAK-003 has been shown to offer wider protection of ...

REJECTING a petition of the defendants in the Dengvaxia cases, the Court of Appeals (CA) has affirmed the ruling of four Quezon City Regional Trial Court (QC-RTC) judges who all agreed to consolidate ...

Takeda had hoped that Eohilia would be the first-ever treatment for EoE, but that crown was snatched by Sanofi and Regeneron ... with approvals for dengue fever vaccine Qdenga and post-transplant ...

In February, Takeda signed an MoU on rare diseases with the Medical Services Administration under the Ministry of Health, in ...

From the company's own site, we can see this pharma brand has a diversified portfolio of therapies across multiple clinical ...

People infected a second time are at especially high risk. There is no specific medication to treat dengue. Japanese ...

Effective dengue prevention requires a combination of vector control and vaccination efforts, a group of physicians said ...

People infected a second time are at especially high risk. There is no specific medication to treat dengue. Japanese ...

In terms of preventing future outbreaks, there are hopes that the newly approved dengue vaccine will assist in tackling the disease, though that is unlikely to be a swift solution. Vaccines may take ...

Argentine health authorities Thursday announced that the Japanese-developed TAK-003 vaccine against dengue was already available in the South American country at a cost of AR$ 37,500 (around US$ ...